Mall PA
Storefront · Summerville, South Carolina, USA

Thorne

“Thorne doesn't just meet the standard, Thorne sets the standard.”Thorne
1984founded
2in the mall
92top Gains Score
2NSF or Informed certified here

In their words

Summarized from Thorne's own site and announcements. These are the brand's claims, not ours.

Thorne started in Seattle in 1984 as a practitioner-focused supplement brand, moved to Sandpoint, Idaho, and later relocated its headquarters and manufacturing to Summerville, South Carolina. It describes itself as a science-driven wellness company drawing on decades of clinical experience, in-house research and data-informed personalized recommendations.

What they say about testing

Thorne says every supplement goes through four rounds of testing, from raw-material purity through finished-product shelf life, follows a 'No List' of excluded fillers and additives, and is made at its own Summerville campus; it carries a large range of NSF Certified for Sport products.

Headquarters
Summerville, South Carolina, USA
Founders
Al Czap
Ownership
Owned by private equity firm L Catterton (took it private in 2023 for about $680M). On Aug 4, 2026 Procter & Gamble announced a deal to buy Thorne for $3.8B, expected to close later in 2026 pending regulatory approval.
Known for
NSF Certified for Sport range, Thorne Creatine, NiaCel (NR), Practitioner-trusted brand

Thorne in the mall

Every Thorne product we carry, scored the same way as everyone else's.

#1$44.00$0.49/dose
Thorne

Creatine

92Gains Score

Single-ingredient 5 g creatine monohydrate from a brand whose sport line is built around NSF Certified for Sport testing.

NSF Certified for SportPowder
#2$74.00$1.23/dose
Thorne

NiaCel 400

90Gains Score

One capsule a day of NR in a hydrogen-malate form plus TMG, NSF Certified for Sport, so it's safe for tested athletes.

NSF Certified for SportCapsuleRumor mill

Rumor mill

NiaCel 400

In 2021 ChromaDex and Dartmouth sued Thorne, alleging NiaCel infringed their NR patents. The case was voluntarily dismissed as moot in January 2024 after the related patent-eligibility appeal ended.

Source 1

Where this comes from